Magnesium aspartate hydrochloride

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Magnesium aspartate hydrochloride is a mineral supplement indicated in magnesium deficiency when the oral route is not available.

Generic Name
Magnesium aspartate hydrochloride
DrugBank Accession Number
DB16619
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 191.85
Monoisotopic: 190.9835771
Chemical Formula
C4H6ClMgNO4
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Treatment ofMagnesium deficiency•••••••••••••••• •••••••••• ••• ••••••••••••••••••• ••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Magnesium aspartate hydrochloride trihydrateB06NP3KG4091198-22-0BBRFANCCCAUJFS-PUAMRSTPSA-L

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
5LK942W2PC
CAS number
28184-71-6
InChI Key
QYOBXHXZJRPWDE-JIZZDEOASA-L
InChI
InChI=1S/C4H7NO4.ClH.Mg/c5-2(4(8)9)1-3(6)7;;/h2H,1,5H2,(H,6,7)(H,8,9);1H;/q;;+2/p-2/t2-;;/m0../s1
IUPAC Name
magnesium(2+) (2S)-2-aminobutanedioate hydrochloride
SMILES
[Mg++].Cl.N[C@@H](CC([O-])=O)C([O-])=O

References

General References
  1. BASG: Magnesiocard i.v. - Ampullen (Magnesium Aspartate) Intravenous Injection [Link]
ChemSpider
9768341

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntravenous737.6 mg
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-3.5Chemaxon
pKa (Strongest Acidic)1.7Chemaxon
pKa (Strongest Basic)9.61Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area106.28 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity48.21 m3·mol-1Chemaxon
Polarizability10.57 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at February 20, 2021 18:24 / Updated at April 30, 2021 13:08